Patents Assigned to Targazyme, Inc.
  • Augmentation of cell therapy efficacy including treatment with alpha 1,3 fucosyltransferase
    Patent number: 11976298
    Abstract: Disclosed are methods, compositions of matter, and kits useful for augmentation of cells through modification of cellular membrane properties following ex vivo treatment.
    Type: Grant
    Filed: September 19, 2018
    Date of Patent: May 7, 2024
    Assignee: Targazyme, Inc.
    Inventors: Stephen D. Wolpe, Leonard Miller, Lynnet Koh, Thomas E. Ichim
  • AUGMENTATION OF CELL THERAPY EFFICACY INCLUDING TREATMENT WITH ALPHA 1-3 FUCOSLYTRANSFERASE
    Publication number: 20140161782
    Abstract: Disclosed are methods, compositions of matter, and kits useful for augmentation of cells through modification of cellular membrane properties following ex vivo treatment.
    Type: Application
    Filed: February 17, 2014
    Publication date: June 12, 2014
    Applicant: Targazyme, Inc.
    Inventors: Stephen D. Wolpe, Leonard Miller, Lynnet Koh